Analysts Expect Syneos Health Inc (NASDAQ:SYNH) to Announce $1.01 Earnings Per Share
Equities analysts forecast that Syneos Health Inc (NASDAQ:SYNH) will post earnings of $1.01 per share for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Syneos Health’s earnings. The highest EPS estimate is $1.03 and the lowest is $0.99. Syneos Health reported earnings of $0.95 per share during the same quarter last year, which would suggest a positive year over year growth rate of 6.3%. The firm is expected to issue its next earnings report on Monday, March 16th.
On average, analysts expect that Syneos Health will report full-year earnings of $3.21 per share for the current financial year, with EPS estimates ranging from $3.19 to $3.23. For the next fiscal year, analysts forecast that the business will report earnings of $3.63 per share, with EPS estimates ranging from $3.60 to $3.68. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Syneos Health.
Syneos Health (NASDAQ:SYNH) last issued its quarterly earnings data on Thursday, October 31st. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.05. Syneos Health had a return on equity of 10.13% and a net margin of 1.86%. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same period last year, the business earned $0.75 EPS. The business’s revenue was up 5.6% on a year-over-year basis.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Financial Gravity Wealth Inc. bought a new stake in shares of Syneos Health during the 2nd quarter worth $29,000. Quest Capital Management Inc. ADV purchased a new stake in Syneos Health in the 3rd quarter worth about $99,000. CSat Investment Advisory L.P. purchased a new stake in Syneos Health in the 2nd quarter worth about $136,000. Convergence Investment Partners LLC purchased a new stake in Syneos Health in the 3rd quarter worth about $147,000. Finally, Tower Research Capital LLC TRC increased its holdings in Syneos Health by 48.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,272 shares of the company’s stock worth $167,000 after acquiring an additional 1,073 shares during the last quarter.
NASDAQ:SYNH traded up $0.69 during trading hours on Thursday, hitting $51.66. 234,374 shares of the company traded hands, compared to its average volume of 566,357. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 1.02. The firm’s 50-day simple moving average is $52.18 and its 200-day simple moving average is $49.67. Syneos Health has a one year low of $36.26 and a one year high of $56.34. The company has a market cap of $5.33 billion, a PE ratio of 19.72, a PEG ratio of 1.74 and a beta of 1.49.
Syneos Health Company Profile
Syneos Health, Inc operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process.
Recommended Story: What is a good rate of return for a mutual fund?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.